IRRAS — Irras AB Share News
0.000.00%
Last trade - 00:00- SEK127.49m
- SEK114.49m
- SEK40.00m
Brief: IRRAS AB Announces FDA Clearance Of New 510(K) Filing To Expand Time Of Use Of Irraflow
Brief: Irras Q3 Net Revenue Rises To SEK 0.9 Million
Brief: IRRAS Q2 EBIT Loss Widens To SEK 40.7 Million
Brief: IRRAS Announces Issuance Of New Patent For Core IRRAflow Technology
Brief: Irras Gets Regulatory Approval For Irraflow In Israel And Costa Rica
Brief: Irras Appoints New CFO
Brief: IRRAS Completes Directed Share Issue Of Around SEK 106 Mln
Brief: Irras Buys Proprietary Assets
Brief: Irras Q1 Operating Loss Widens To SEK 39.1 Million
Brief: Irras Provides Update On CE Mark Re-Certification Of IRRAflow
Brief: Irras Establishes Collaborative Relationship With AMI-USC
Brief: Irras Evaluates Possible Listing On Nasdaq Stockholm's Main Market
Brief: Irras Presents New Financial Targets
Brief: Irras Q4 EBIT Loss Widens To SEK 50.1 Million
Brief: Irras Q3 EBIT Loss Sek 40.0 Million
Brief: Irras: Update On Recertification Process Of CE Mark For Irraflow Catheter
Brief: Irras To Participate In Key Upcoming Neurosurgery Conferences
Brief: Irras Q2 EBIT Loss Widens To SEK 32.1 Mln
Brief: Irras Receives Clearance For Irraflow In The US